November 19, 2025
Island Pharmaceuticals (ASX:ILA) strengthens regulatory position as FDA confirms animal rule pathway and PRV eligibility for Galidesivir
Dr David Foster says the FDA’s confirmation of Galidesivir’s regulatory pathway marks a major milestone for Island Pharmaceuticals.